Literature DB >> 9025785

Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment.

J Vinholes1, R Coleman, R Eastell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9025785     DOI： 10.1016/s0305-7372(96)90021-3

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  17 in total

1.  1,25-Dihydroxyvitamin D(3) regulates PTHrP expression via transcriptional, post-transcriptional and post-translational pathways.

Authors:  Vandanajay Bhatia; Ramanjaneya V Mula; Miriam Falzon
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

2.  Head-to-Head Evaluation of 18F-FES and 18F-FDG PET/CT in Metastatic Invasive Lobular Breast Cancer.

Authors:  Gary A Ulaner; Komal Jhaveri; Sarat Chandarlapaty; Vaios Hatzoglou; Christopher C Riedl; Jason S Lewis; Audrey Mauguen
Journal:  J Nucl Med       Date:  2020-07-17       Impact factor: 10.057

3.  Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.

Authors:  J Zhang; J Dai; Y Qi; D L Lin; P Smith; C Strayhorn; A Mizokami; Z Fu; J Westman; E T Keller
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

4.  Predictive implications of bone turnover markers after palliative treatment with (186)Re-HEDP in hormone-refractory prostate cancer patients with painful osseous metastases.

Authors:  Athanasios Zafeirakis; Georgios Papatheodorou; Athanasios Arhontakis; Athanasios Gouliamos; Lambros Vlahos; Georgios S Limouris
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

Review 5.  Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer.

Authors:  Michael A Jacobs; Li Pan; Katarzyna J Macura
Journal:  Semin Roentgenol       Date:  2009-04       Impact factor: 0.800

6.  Osteoblastic response as a healing reaction to chemotherapy mimicking progressive disease in patients with small cell lung cancer.

Authors:  Joerg Stattaus; Steffen Hahn; Thomas Gauler; Wilfried Eberhardt; Stefan P Mueller; Michael Forsting; Susanne C Ladd
Journal:  Eur Radiol       Date:  2008-08-02       Impact factor: 5.315

Review 7.  Spinal metastasis in the elderly.

Authors:  Max Aebi
Journal:  Eur Spine J       Date:  2003-09-23       Impact factor: 3.134

8.  Bone integrity and bone metastases in breast cancer.

Authors:  Catherine Van Poznak; Cristina Nadal
Journal:  Curr Oncol Rep       Date:  2006-01       Impact factor: 5.075

9.  EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.

Authors:  Vandanajay Bhatia; Manjit K Saini; Xiaoli Shen; Lian X Bi; Suimin Qiu; Nancy L Weigel; Miriam Falzon
Journal:  Mol Cancer Ther       Date:  2009-07-07       Impact factor: 6.261

Review 10.  Imaging response to systemic therapy for bone metastases.

Authors:  Tobias Bäuerle; Wolfhard Semmler
Journal:  Eur Radiol       Date:  2009-05-26       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.